Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis
AJ Templeton, O Ace, MG McNamara… - … , biomarkers & prevention, 2014 - AACR
Background: Inflammation influences cancer development and progression. An elevated
platelet to lymphocyte ratio (PLR), a marker of inflammation, has been linked to poor …
platelet to lymphocyte ratio (PLR), a marker of inflammation, has been linked to poor …
[HTML][HTML] Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis
X Zhang, W Zhao, Y Yu, X Qi, L Song, C Zhang… - World journal of surgical …, 2020 - Springer
Background Pre-treatment PLR (platelet-lymphocyte ratio) was reported to be associated
with the prognosis in gastric cancer (GC), but the results remain inconclusive. This meta …
with the prognosis in gastric cancer (GC), but the results remain inconclusive. This meta …
Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer
M Omar, O Tanriverdi, S Cokmert… - The clinical …, 2018 - Wiley Online Library
Objectives In this study, they investigated whether mean thrombocyte volume (MPV) and
MPV/platelet count ratio have a prognostic significance in advanced NSCLC or not. Methods …
MPV/platelet count ratio have a prognostic significance in advanced NSCLC or not. Methods …
Prognostic value of platelet-to-lymphocyte ratio in oncologic outcomes of esophageal cancer: a systematic review and meta-analysis
X Zhang, Y Wang, L Zhao, S Sang… - … International Journal of …, 2018 - journals.sagepub.com
The platelet-to-lymphocyte ratio (PLR) is a useful prognostic factor in several cancers.
However, the prognostic role of PLR in esophageal cancer remains controversial. The aim of …
However, the prognostic role of PLR in esophageal cancer remains controversial. The aim of …
Peripheral venous blood platelet-to-lymphocyte ratio (PLR) for predicting the survival of patients with gastric cancer treated with SOX or XELOX regimen neoadjuvant …
L Chen, Y Hao, X Cong, M Zou, S Li… - … in cancer research …, 2019 - journals.sagepub.com
Background: Inflammation plays an important role in tumor progression. Predicting survival
is remarkably difficult in patients with gastric cancer receiving neoadjuvant chemotherapy …
is remarkably difficult in patients with gastric cancer receiving neoadjuvant chemotherapy …
[HTML][HTML] Increased platelet distribution width predicts poor prognosis in melanoma patients
N Li, Z Diao, X Huang, Y Niu, T Liu, Z Liu, R Wang… - Scientific reports, 2017 - nature.com
Activated platelets promote cancer progression and metastasis. Nevertheless, the
prognostic value of platelet indices in melanoma had been rarely reported. The aim of this …
prognostic value of platelet indices in melanoma had been rarely reported. The aim of this …
Mean platelet volume could be a possible biomarker for papillary thyroid carcinomas
Thyroid cancer is the most prevalent endocrine cancer and is evident in nearly 5% of thyroid
nodules. The correlation between mean platelet volume (MPV) and many other cancer types …
nodules. The correlation between mean platelet volume (MPV) and many other cancer types …
Prognostic impact of increased perioperative platelet count in gastric cancer patients
SE Oh, JE Seo, JY An, JH Lee, TS Sohn, JM Bae… - Journal of Surgical …, 2019 - Elsevier
Background Solid tumors are a common cause of secondary (reactive) thrombocytosis, a
paraneoplastic syndrome that is also a prognostic factor for various cancers. However, cutoff …
paraneoplastic syndrome that is also a prognostic factor for various cancers. However, cutoff …
Platelet indices in patients with colorectal cancer
B Karagöz, İ Sücüllü, Ö Sayan, O Bilgi, T Tuncel… - Open …, 2010 - degruyter.com
The interaction between cancer cells and platelets has been known for a long time. Although
platelet indices have been also investigated in several clinical settings, it has not been …
platelet indices have been also investigated in several clinical settings, it has not been …
[HTML][HTML] Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: a multicenter study
M Gunaldi, S Goksu, D Erdem, S Gunduz… - … journal of clinical and …, 2015 - ncbi.nlm.nih.gov
Background: Increasing amounts of evidence suggest patient-related systemic inflammatory
response (SIR) as a powerful prognostic factor in cancer and applicability of SIR as a …
response (SIR) as a powerful prognostic factor in cancer and applicability of SIR as a …